Home
IMCR
IMCR News

Latest Immunocore Holdings plc (IMCR) News on August 15, 2025

Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength?

Zacks

2 months ago

Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength?

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

Zacks

2 months ago

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

Zacks

2 months ago

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet

Zacks

2 months ago

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet

Immunocore to present at the 2025 Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Immunocore to present at the 2025 Jefferies Global Healthcare Conference

MT Newswires

3 months ago

Deutsche Bank Initiates Immunocore Holdings at Buy With $65 Price Target

Is it a Good Idea to Invest in Immunocore Stock Right Now?

Zacks

3 months ago

Is it a Good Idea to Invest in Immunocore Stock Right Now?

MT Newswires

3 months ago

Oppenheimer Adjusts Price Target on Immunocore Holdings to $86 From $85, Maintains Outperform Rating

MT Newswires

3 months ago

Sector Update: Health Care Stocks Gain Wednesday Afternoon

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics

Zacks

3 months ago

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics

MT Newswires

3 months ago

Immunocore Holdings' Q1 Swings to Net Income, Revenue Rises

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire

3 months ago

Immunocore reports first quarter financial results and provides a business update

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet

Zacks

4 months ago

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet

MT Newswires

4 months ago

Mizuho Adjusts Price Target on Immunocore Holdings to $33 From $38, Keeps Neutral Rating

Immunocore to present at upcoming investor conferences

GlobeNewswire

4 months ago

Immunocore to present at upcoming investor conferences

Immunocore Holdings plc (IMCR): Among Stocks Receiving the Most Insider Love in March

Insider Monkey

5 months ago

Immunocore Holdings plc (IMCR): Among Stocks Receiving the Most Insider Love in March

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?

Zacks

5 months ago

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

GlobeNewswire

5 months ago

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

Immunocore to present at upcoming investor conferences

GlobeNewswire

5 months ago

Immunocore to present at upcoming investor conferences

The Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

6 months ago

The Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New Forecasts

Immunocore Holdings Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

6 months ago

Immunocore Holdings Full Year 2024 Earnings: Misses Expectations

Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

6 months ago

Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Thomson Reuters StreetEvents

6 months ago

Q4 2024 Immunocore Holdings PLC Earnings Call

MT Newswires

6 months ago

Immunocore Q4 Net Loss Widens, Revenue Rises

Immunocore reports fourth quarter and full year 2024 financial results and provides a business update

GlobeNewswire

6 months ago

Immunocore reports fourth quarter and full year 2024 financial results and provides a business update

Earnings To Watch: Immunocore Holdings PLC (IMCR) Reports Q4 2024 Result

GuruFocus.com

6 months ago

Earnings To Watch: Immunocore Holdings PLC (IMCR) Reports Q4 2024 Result

Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO

Pharma Voice

6 months ago

Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO

Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025

GlobeNewswire

6 months ago

Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?

Zacks

6 months ago

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade

Zacks

7 months ago

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade

Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference

Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

7 months ago

Immunocore Names Travis Coy Chief Financial Officer

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development

GlobeNewswire

7 months ago

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development

MT Newswires

8 months ago

Immunocore Doses First Patient in Phase 1 Trial of Potential Cancer Treatment

Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME

GlobeNewswire

8 months ago

Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME

Immunocore doses first subject in gastrointestinal cancer therapy trial

Clinical Trials Arena

8 months ago

Immunocore doses first subject in gastrointestinal cancer therapy trial

Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers

GlobeNewswire

8 months ago

Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

Benzinga

8 months ago

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

MT Newswires

8 months ago

Morgan Stanley Downgrades Immunocore Holdings to Equalweight From Overweight, Cuts Price Target to $35 From $74

All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy

Zacks

8 months ago

All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy

Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial

TipRanks

8 months ago

Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial

MT Newswires

8 months ago

Immunocore Enrolls First Patient in Phase 3 Uveal Melanoma Trial

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

GlobeNewswire

8 months ago

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

MT Newswires

8 months ago

Immunocore Says UK NICE Recommends Kimmtrak for Funding Through National Health Service in England

Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma

GlobeNewswire

8 months ago

Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma

Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect?

Zacks

9 months ago

Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect?

Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To Explode

Insider Monkey

9 months ago

Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To Explode

Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

9 months ago

Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?

Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know

Zacks

9 months ago

Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know

Immunocore to present at upcoming investor conferences

GlobeNewswire

9 months ago

Immunocore to present at upcoming investor conferences

Immunocore reports third quarter financial results and provides a business update

GlobeNewswire

9 months ago

Immunocore reports third quarter financial results and provides a business update

Immunocore (IMCR) Upgraded to Buy: Here's Why

Zacks

9 months ago

Immunocore (IMCR) Upgraded to Buy: Here's Why

MT Newswires

10 months ago

--UBS Initiates Immunocore Holdings With Sell Rating, $24 Price Target

Immunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ...

GuruFocus.com

10 months ago

Immunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ...

Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now

Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy

Insider Monkey

a year ago

Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy

Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales

Immunocore Holdings plc (IMCR): Short Seller Sentiment is Bearish on This Cancer Stock

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR): Short Seller Sentiment is Bearish on This Cancer Stock

Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer

GlobeNewswire

a year ago

Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer

Immunocore to present at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

a year ago

Immunocore to present at the 2024 Cantor Global Healthcare Conference

Significant Portfolio Addition: T. Rowe Price Investment Management, Inc. ...

GuruFocus.com

a year ago

Significant Portfolio Addition: T. Rowe Price Investment Management, Inc. ...

Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds

MT Newswires

a year ago

Immunocore Finance Chief Brian Di Donato to Resign

Immunocore announces transition of Chief Financial Officer

GlobeNewswire

a year ago

Immunocore announces transition of Chief Financial Officer

MT Newswires

a year ago

Mizuho Adjusts Immunocore Holdings' PT to $72 From $88, Keeps Outperform Rating

The Immunocore Holdings plc (NASDAQ:IMCR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

a year ago

The Immunocore Holdings plc (NASDAQ:IMCR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

MT Newswires

a year ago

Immunocore Shares Rise After Reporting Narrower Q2 Net Loss, Higher Revenue

Immunocore reports second quarter financial results and provides a business update

GlobeNewswire

a year ago

Immunocore reports second quarter financial results and provides a business update

Immunocore to report second quarter 2024 financial results and host call on August 8, 2024

GlobeNewswire

a year ago

Immunocore to report second quarter 2024 financial results and host call on August 8, 2024

Is There An Opportunity With Immunocore Holdings plc's (NASDAQ:IMCR) 32% Undervaluation?

Simply Wall St.

a year ago

Is There An Opportunity With Immunocore Holdings plc's (NASDAQ:IMCR) 32% Undervaluation?

MT Newswires

a year ago

Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment

Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma

GlobeNewswire

a year ago

Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Dow Jones Falls On Jobs Report; GameStop Plunges Ahead Of 'Roaring Kitty' Live Event

Investor's Business Daily

a year ago

Dow Jones Falls On Jobs Report; GameStop Plunges Ahead Of 'Roaring Kitty' Live Event

Can DocuSign's AI offering accelerate growth?

Yahoo Finance Video

a year ago

Can DocuSign's AI offering accelerate growth?

Lab-on-a-Chip and Microfluidics World Congress 2024: 3-Day Conference (Laguna Hills, United States - November 18-20, 2024) Covering Technologies, Companies and Commercialization

GlobeNewswire

a year ago

Lab-on-a-Chip and Microfluidics World Congress 2024: 3-Day Conference (Laguna Hills, United States - November 18-20, 2024) Covering Technologies, Companies and Commercialization

Analysis-Mexico investors worry lopsided vote could threaten rule of law

Reuters

a year ago

Analysis-Mexico investors worry lopsided vote could threaten rule of law

AI Boom Giving Taiwan Semiconductor Sales A Boost

Investor's Business Daily

a year ago

AI Boom Giving Taiwan Semiconductor Sales A Boost

Taxes Served Corp. Acquires Blue Mountain Bookkeeping LLC to Enhance Tax and Bookkeeping Services

PR Newswire

a year ago

Taxes Served Corp. Acquires Blue Mountain Bookkeeping LLC to Enhance Tax and Bookkeeping Services

Smart Irrigation Market worth $3.0 billion by 2029 - Exclusive Report by MarketsandMarkets™

PR Newswire

a year ago

Smart Irrigation Market worth $3.0 billion by 2029 - Exclusive Report by MarketsandMarkets™

Business Wire

a year ago

Airstar Bank, with AMTD as a co-founder, successfully introduces Futu as A New Shareholder

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

GlobeNewswire

a year ago

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024

GlobeNewswire

a year ago

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024

Immunocore to present at the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Immunocore to present at the Jefferies Global Healthcare Conference

MT Newswires

a year ago

Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3

Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma

GlobeNewswire

a year ago

Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma

Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.

Barrons.com

a year ago

Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.

Analysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter Report

Simply Wall St.

a year ago

Analysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter Report

MT Newswires

a year ago

Immunocore Holdings' Shares Fall After Q1 Net Loss Widens

Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts

GuruFocus.com

a year ago

Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire

a year ago

Immunocore reports first quarter financial results and provides a business update

MT Newswires

a year ago

Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target

Share on Social Networks: